These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 3260072)
21. Biochemical, molecular characterization, and glycoproteomic analyses of alpha(1)-proteinase inhibitor products used for replacement therapy. Kolarich D; Turecek PL; Weber A; Mitterer A; Graninger M; Matthiessen P; Nicolaes GA; Altmann F; Schwarz HP Transfusion; 2006 Nov; 46(11):1959-77. PubMed ID: 17076852 [TBL] [Abstract][Full Text] [Related]
22. Pain and cyanosis associated with alpha 1-proteinase inhibitor. Clark JA; Gross TP Am J Med; 1992 Jun; 92(6):621-6. PubMed ID: 1534964 [TBL] [Abstract][Full Text] [Related]
23. Quantity of anti-leucoprotease relative to alpha 1-proteinase inhibitor in peripheral airspaces of the human lung. Kramps JA; Franken C; Dijkman JH Clin Sci (Lond); 1988 Oct; 75(4):351-3. PubMed ID: 2461824 [TBL] [Abstract][Full Text] [Related]
24. Unglycosylated rat alpha 1-proteinase inhibitor has a six-fold shorter plasma half-life than the mature glycoprotein. Weber W; Steube K; Gross V; Tran-Thi TA; Decker K; Gerok W; Heinrich PC Biochem Biophys Res Commun; 1985 Jan; 126(1):630-5. PubMed ID: 3871610 [TBL] [Abstract][Full Text] [Related]
25. Inactivation of alpha-1-proteinase inhibitor by neutrophil metalloproteinases. Crucial role of the myeloperoxidase system and effects of the anti-inflammatory drug nimesulide. Ottonello L; Dapino P; Dallegri F Respiration; 1993; 60(1):32-7. PubMed ID: 8385794 [TBL] [Abstract][Full Text] [Related]
26. Identification of plasma proteins contained in bronchoalveolar fluid from Macacus cynomolgus. Hannothiaux MH; Scharfman A; Leger D; Van Brussel E; Lafitte JJ; Roussel P Comp Biochem Physiol B; 1989; 92(4):645-50. PubMed ID: 2785896 [TBL] [Abstract][Full Text] [Related]
27. [Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema]. Trefz G; Heck B; Schulz V; Ebert W Pneumologie; 1989 Aug; 43(8):446-51. PubMed ID: 2788886 [TBL] [Abstract][Full Text] [Related]
28. Effect of nonsteroidal antiinflammatory drugs on the neutrophil promoted inactivation of alpha-1-proteinase inhibitor. Dallegri F; Ottonello L; Dapino P; Sacchetti C J Rheumatol; 1992 Mar; 19(3):419-23. PubMed ID: 1578457 [TBL] [Abstract][Full Text] [Related]
29. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin. Casolaro MA; Fells G; Wewers M; Pierce JE; Ogushi F; Hubbard R; Sellers S; Forstrom J; Lyons D; Kawasaki G J Appl Physiol (1985); 1987 Nov; 63(5):2015-23. PubMed ID: 3500941 [TBL] [Abstract][Full Text] [Related]
30. Alteration of the pharmacokinetics of small proteins by iodination. Bauer RJ; Leigh SD; Birr CA; Bernhard SL; Fang M; Der K; Ihejeto NO; Carroll SF; Kung AH Biopharm Drug Dispos; 1996 Dec; 17(9):761-74. PubMed ID: 8968529 [TBL] [Abstract][Full Text] [Related]
31. Enzyme-linked immunoassay for human granulocyte elastase in complex with alpha 1-proteinase inhibitor. Neumann S; Hennrich N; Gunzer G; Lang H Adv Exp Med Biol; 1984; 167():379-90. PubMed ID: 6608861 [TBL] [Abstract][Full Text] [Related]
32. Turnover of *I-protein C inhibitor and *I-alpha 1-antitrypsin and their complexes with activated protein C. Laurell M; Stenflo J; Carlson TH Blood; 1990 Dec; 76(11):2290-5. PubMed ID: 2175221 [TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR; Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480 [TBL] [Abstract][Full Text] [Related]